UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D

Quality of life research, 2016-03, Vol.25 (3), p.707-719

2016

Volltextzugriff (PDF)

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan

Value in health, 2016-07, Vol.19 (5), p.648-654

2016

Volltextzugriff (PDF)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Health and quality of life outcomes, 2020-11, Vol.18 (1), p.354-354, Article 354

2020

Volltextzugriff (PDF)

Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan

Clinical drug investigation, 2022-07, Vol.42 (7), p.599-609

2022

Volltextzugriff (PDF)

Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients’ Health Status in Greater Detail?

Medical decision making, 2022-01, Vol.42 (1), p.60-67

2022

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan

The Journal of pediatrics, 2023-02, Vol.253, p.101-106.e2

2023

Volltextzugriff (PDF)

Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups

Pediatric surgery international, 2022-04, Vol.38 (4), p.547-554

2022

Volltextzugriff (PDF)

Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study

Health and quality of life outcomes, 2024-01, Vol.22 (1), p.8-8, Article 8

2024

Volltextzugriff (PDF)

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study

PharmacoEconomics, 2018-02, Vol.36 (2), p.215-223

2018

Volltextzugriff (PDF)

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L

Health and quality of life outcomes, 2023-01, Vol.21 (1), p.3-3, Article 3

2023

Volltextzugriff (PDF)

Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial

The lancet oncology, 2016, Vol.17 (1), p.90-98

2016

Volltextzugriff (PDF)

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients

PloS one, 2019-01, Vol.14 (1), p.e0208118-e0208118

2019

Volltextzugriff (PDF)

How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance

BMC health services research, 2024-03, Vol.24 (1), p.334-14, Article 334

2024

Volltextzugriff (PDF)

Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial

Breast cancer research and treatment, 2021-08, Vol.188 (3), p.675-683

2021

Volltextzugriff (PDF)

QALY and Productivity Loss: Empirical Evidence for “Double Counting”

Value in health, 2013-06, Vol.16 (4), p.581-587

2013

Volltextzugriff (PDF)

Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL)

Quality of life research, 2012-03, Vol.21 (2), p.335-340

2012

Volltextzugriff (PDF)

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.735-747

2011

Volltextzugriff (PDF)

Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P

Quality of life research, 2019-09, Vol.28 (9), p.2383-2391

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

BMC cancer, 2017-11, Vol.17 (1), p.773-773, Article 773

2017

Volltextzugriff (PDF)

Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems”

Quality of life research, 2020-03, Vol.29 (3), p.755-763

2020

Volltextzugriff (PDF)

Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial

Supportive care in cancer, 2012-12, Vol.20 (12), p.3355-3364

2012

Volltextzugriff (PDF)

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer

Oncology, 2018-01, Vol.94 (2), p.107-115

2018

Volltextzugriff (PDF)

Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery

Breast cancer (Tokyo, Japan), 2017-03, Vol.24 (2), p.288-298

2017

Volltextzugriff (PDF)

Evidence-Based Risk Factors for Seroma Formation in Breast Surgery

Japanese journal of clinical oncology, 2006-04, Vol.36 (4), p.197-206

2006

Volltextzugriff (PDF)

Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1368-1374

2009

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(130)

Sprache

Englisch
(116)
Japanisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan

Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients’ Health Status in Greater Detail?

Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan

Direct health care cost of treatment and medication of biliary atresia patients using the National Database of Health Insurance Claims and Specific Health Checkups

Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study

Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study

Impacts of the preceding cancer-specific health-related quality of life instruments on the responses to the subsequent EQ-5D-5L

Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial

A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients

How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance

Impact of chemotherapy on cognitive functioning in older patients with HER2-positive breast cancer: a sub-study in the RESPECT trial

QALY and Productivity Loss: Empirical Evidence for “Double Counting”

Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL)

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery

Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged “no-problems”

Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer

Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery

Evidence-Based Risk Factors for Seroma Formation in Breast Surgery

Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial

Suchergebnisse filtern